• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

An investigation of gene expression profile

Research Project

Project/Area Number 13670578
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionJIKEI UNIVERSITY SCHOOL OF MEDICINE (2002-2003)
Japanese Foundation For Cancer Research (2001)

Principal Investigator

AIBA Keisuke  JIKEI UNIVERSITY SCHOOL OF MEDICINE, Dept.of Clinical Oncology, Lecturer, 医学部, 講師 (90150086)

Co-Investigator(Kenkyū-buntansha) KOBAYASHI Tadashi  JIKEI UNIVERSITY SCHOOL OF MEDICINE, Dept.of Clinical Oncology, Associate Professor, 医学部, 助教授 (50147310)
宇野 真二  東京慈恵会医科大学, 医学部, 助手 (70328293)
水沼 信之  財団法人 癌研究会, 癌化学療法センター・臨床部, 研究員 (40311229)
伊藤 良則  財団法人 癌研究会, 癌化学療法センター・臨床部, 研究員 (00261131)
堀越 昇  財団法人 癌研究会, 癌化学療法センター・臨床部, 研究員 (00085648)
Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2003: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2002: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2001: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywordsgastrointestinal cancer / 5-fluorouracil / gene expression / OPRT / DNA arrray / predictive factor / 耐性遺伝子
Research Abstract

We investigated the correlation between gene expression profiles and anticancer drug sensitivity using six human colorectal cancer cell lines, C1, H630, H508, H716, C2A, and C4. Anticancer drug sensitivity was determined by MTT assay after 96 hours drug exposure to respective cancer cell lines. The drugs used were 5-fluorouracil(5-FU) and raltitrexed (RTX) which were typically categorized as thymidylate synthase(TS) inhibitor and were one of the most active drugs against gastrointestinal cancers. IC50's of each drug were as follows(5-FU:μM, RTX:nM) ; C1(0.18、-)H630 (39.0、9.3) H508 (0.06、-) H716 (813、65.0) C2A (11.0, 6.6) C4 (0.62、0.82).Various gene expression profiles in six cell lines were evaluated using DNA microarray assay enabling us to explore many genes of interest. which were TS, DPD, NADPH, cytochromeP450, glutathione, GST, GSTπ, cMOAT, MDR1, MRP, α tubulin, β tubulin, orotate phosphoribosyltransferase (OPRT), proliferating cyclic nuclear antigen(PCNA) and so forth. Significant close correlation between 5-FU sensitivity and gene expression level of OPRT and PCNA were revealed after multivariate statistical analysis (p<0.05). Since increased level,of OPRT gene expression can be related to increased level of 5-fluorouridinemonophosphate generation, it appeared to be quite reasonable for. 5-FU sensitivity. Gene expression level of thymidine phosphorylase (TP) and DPD were not correlated with 5-FU sensitivity. RTX sensitivity was close correlated with 5-FU sensitivity and TS binding capacity, indicating that both 5-FU and RTX shared the same target of TS..
While TS, DPD and TP have been considered to be pivotal factors regarding 5-FU sensitivity in view of biochemical or gene expression profile aspects, the level of OPRT gene expression can be also important in 5-FU sensitivity.

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (60 results)

All Other

All Publications (60 results)

  • [Publications] Koizumi W, Aiba K et al.: "Phase I dose-escalation trial of ZD9331 in Japanese patients with refractory solid malignancies."Anticancer Drugs. 14. S1-S5 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takahashi S, Aiba K, et al.: "Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels"Endocr Relat Cancer. 10. 403-407 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Aiba K, et al.: "Globalization of clinical trials"Jap J Cancer Chemother. 30. 555-565 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K: "New Agents in Gastric Cancer Chemotherapy"Jpn J Cancer Clin. 49. 575-581 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Uno S, Aiba K: "Adverse reactions of cancer chemotherapy and fluid replacement"Nippon Rinsho. 61. 923-928 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kobayashi T, Uno S, Aiba K, et al.: "Standard regimens employed in preoperative chemo-Therapy or breast cancer. Rational in chooslnffadequate regimens and theoretical foundation"J Clin Surg. 58. 893-901 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arakawa Y, Mizunuma N, Aiba K, et al.: "Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report"Jap J Cancer Chemother. 29. 2561-2564 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Aiba K, et al.: "Globalization of anti-cancer therapies"Jap J Cancer Chemother. 29. 205-214 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sugiyama K, Omachi K, Ito Y, Aiba K, et al.: "Irinotecan hydrochloride for the treatment of recurrent and refractory non-Hodgkin lymphoma : a singl institution experience."Cancer. 94. 594-600 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Saeki T, Kawai K, Aiba K, et al.: "Comparison of management of advanced cancer in various organs."Jap J Cancer Chemother. 28. 1845-1855 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito Y, Aiba K, et al.: "Dose-finding phase 1 study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer."Int J Clin Oncol. 6. 242-247 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K: "Optimal dose and schedule of 5-fluorouracil"Jap J Cancer Chemother. 28. 1368-1379 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikosh N, Aiba K, Takahashi S, Hatake K.: "Drug resistance of molecular targeted chemotherapy"Practical Oncology. 14. 14-17 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Hashimoto D, Aiba K: "Cancer Chemotherapy"General Gastrointestinal Care. 6. 17-121 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Mizunuma N, Aiba K: "Cancer chemotherapy for Gastrointestinal tumors."General Gastrointestinal Care. 6. 137-143 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Saijo N, Aiba K, et al.: "Platinum compounds in cancer therapy-past, present, and future"Jap J Cancer Chemother. 28. 625-635 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K, Ogawa M: "Upper gastrointestinal tumors(Cancer Chemotherapy & Biological Response Modifiers. Schilsky R, Sondel P and Giaccone G eds.annual 19)"Elsevier Science, Oxford. 23 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K: "Evoluion of leucovorin and 5-fluorouracil combination chemotherapy."Cepri.Tokyo. 86 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K: "Fluoropyrimidines and purine derivertives for cancer chemotherapy.(Mechanisms of anticancer drug resistance and its reversal. Ohnuma N and Takemura Y eds.)"Uchudoyagishoten, Tokyo. 10 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K: "Upper gastrointestinal tumors(Cancer Chemotherapy and Biological Response Modifiers, Annual 19.Giaccone G, Schilsky R and Sondel P eds.)"Elsevier Science, Amsterdam. 10 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K: "Fluoropyrimidines(Therapy guide. Wada I, Ohkubo A, Nagata N, Yazaki Y eds.)"Bunkodo. 8 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K, Ogawa M.: "Upper gastrointestinal tumors."Cancer Chemotherapy & Biological Response Modifiers. Schilsky R, Sondel P and Giaccone G eds. annual 19, Elsevier Science, Oxford. 485-508 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Koizumi W, Aiba K, et al.: "Phase I dose-escalation trial of ZD9331 in Japanese patients with refractory solid malignancies."Anticancer Drugs. 14:Suppl 1. S1-S5 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takahashi S, Hakuta M, Aiba K, et al.: "Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels."Endocr Relat Cancer. 10. 403-407 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Aiba K, et al.: "Globalization of clinical trials"Jap J Cancer Chemother. 30. 555-565 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K.: "New Agents in Gastric Cancer Chemotherapy."Jpn J Cancer Clin. 49. 555-565 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Uno S, Aiba K.: "Adverse reactions of cancer chemotherapy and fluid replacement."Nippon Rinsho.. 61. 923-928 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kobayashi T, Uno S, Aiba K, et al.: "Standard regimens employed in preoperative chemo-Therapy for breast cancer. Rational in choosing adequate regimens and theoretical foundation."J Clin Surg. 58. 893-901 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Atakawa Y, Mizunuma N, Aiba K, et al.: "Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report"Jap J Cancer Chemother. 29. 2561-2564 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Aiba K, et al.: "Globalization of anti-cancer therapies"Jap J Cancer Chemother. 29. 205-214 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sugiyama K, Omachi K, Fujiwara K, Saotome T, Mizunuma N, Takahashi S, Ito Y, Aiba K, et al.: "Irinotecan hydrochloride for the treatment of recurrent and refractory non-Hodgkin lymphoma : a single institution experience."Cancer. 94. 594-600 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Saeki T, Kawai K, Aiba K, et al.: "Comparison of management of advanced cancer in various organs."Jap J Cancer Chemother. 28. 1845-1855 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito Y, Aiba K, et al.: "Dose-finding phase I study of simultaneous. weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer."Int J Chin Oncol.. 6. 242-247 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K.: "Evolujon of leucovorin and 5-fluorouracil combination chemotherapy."Cepri.Tokyo. 1-86 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K.: "Optimal dose and schedule of 5-fluorouracil"Jap J Cancer Chemother. 28. 1368-1379 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K.: "Fluoropyrimidines and purine derivertives for cancer chemotherapy."Mechanisms of anticancer drug resistance and its reversal. (Ohnuma N and Takemura Y eds.) (Uchudoyagishoten), Tokyo. 211-221 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K.: "Upper gastrointestinal tumors."Cancer Chemotherapy and Biological Response Modifiers, Annual 19. (Giaccone G, Schilsky R and Sondel P eds.) (Elsevier Science), Amsterdam. 535-545 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K, Takahashi S, Hatake K.: "Drug resistance of molecular targeted chemotherapy."Practical Oncology.. 14. 14-17 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K.: "Fluoropyrimidines"Therapy guide. (Wada I, Ohkubo A, Nagata N, and Yazaki Y eds.) (Bunkodo). 915-923 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Hashimoto D, Aiba K.: "Cancer Chemotherapy"General Gastrointestinal Care. 6. 17-121 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Horikoshi N, Mizununia N, Aiba K.: "Cancer chemotherapy for Gastrointestinal tumors."General Gastrointestinal Care. 6. 137-143 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akaza H, Saijo N, Aiba K, et al.: "Platinum compounds in cancer therapy-past, present, and future"Jap J Cancer Chemother. 28. 625-635 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Aiba K et al.: "Upper gastrointestinal tumors"Cancer Chemotherapy & Biological Response Modifiers. 19. 485-508 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Koizumi W, Aiba K et al.: "Phase I dose-escalation trial of ZD9331 in Japanese patients with refractory, solid malignancies"Anticancer Drugs. 14・Suppl 1. S1-S5 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takahashi S, Aiba K et al.: "Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels."Endocr Relat Cancer. 10・3. 403-407 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Aiba K: "New agents in gastric cancer chemotherapy"Jpn J Cancer Clin. 49・7. 575-581 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Akaza H, Aiba K et al.: "Globalization of clinical trials"Jap J Cancer Chemother. 30・4. 555-565 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 相羽 惠介: "消化器がん 化学療法、注目される抗癌剤 タキサン系薬剤"日本メディカルセンター. 17 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Aiba K.: "The evolution of oral chemotherapeutic drugs in outpatients management"Biotherapy. 16(4). 378-384 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Akaza H, Aiba K et al.: "Globalization of anti-cancer therapies"Jpn J Cancer Chemother. 29(2). 205-214 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Arakawa Y, Mizunuma N, Aiba K et al.: "Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen-a case report"Jpn J Cancer Chemother. 29(13). 2561-2564 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sugiyama K et al.: "Irinotecan hydrochloride for the treatment of recurrent and refractory non-Hodgkin lymphoma : a single institution experience"Cancer. 94(3). 594-600 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Aiba K.: "Upper gastrointestinal tumors. in Cancer Chemotherapy & Biological Response Modifiers"Elsevier Science (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] eisuke Aiba.: "Upper gastrointestinal tumors"Cancer Chemotherapy and Biological Response Modifiers. 19. 535-545 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 相羽惠介: "5-Fluorouracil(5-FU) 抗癌剤の至適投与方法を検証する"癌と化学療法. 28(10). 1368-1379 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 相羽惠介: "Leucovorin・5-Fluorouracil療法の変遷"Leucovorin・5-Fluorouracil療法の変遷. 1-86 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 相羽惠介: "胃癌-癌治療2001年・その1-"Practical Oncology. 14(1). 8-10 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 堀越昇, 相羽恵介, 高橋俊二, 畠清彦: "薬剤耐性-癌の分子標的治療"Practical Oncology. 14(3). 14-17 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 赤座英之, 佐伯俊昭, 相羽恵介: "各癌腫における進行癌の治療方針の比較と新薬開発の必要性"癌と化学療法. 28(12). 1845-1855 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 相羽惠介: "フッ化ピリミジン系薬剤およびプリン代謝拮抗剤-各薬剤に特異的な耐性機構とその克服.癌の薬剤耐性とその克服-基礎と臨床-"宇宙堂八木書店. 10 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi